We are live on
!
Find out more
GC
Guggenheim Capital Portfolio holdings
AUM
$12.9B
1-Year Est. Return
27.3%
This Fund
S&P 500
This Quarter
Est. Return
+5.8%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$42.2B
AUM Growth
-$360M
(-0.85%)
Cap. Flow
-$2.32B
Cap. Flow
% of AUM
-5.5%
Top 10 Holdings %
Top 10 Hldgs %
7.6%
Holding
2,945
New
147
Increased
1,226
Reduced
1,320
Closed
236
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$859M |
| 2 |
Apple
AAPL
|
+$61.2M |
| 3 |
Norwegian Cruise Line
NCLH
|
+$56M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$55.7M |
| 5 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$40.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$106M |
| 2 |
ULQ
CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF
ULQ
|
+$84.5M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$53.6M |
| 4 |
Applied Materials
AMAT
|
+$37.5M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$37.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.48% |
| 2 | Financials | 12.95% |
| 3 | Healthcare | 12.03% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Lineage Cell Therapeutics
LCTX
$277M
| $63K | ﹤0.01% |
33,967
-5,525
| -14% | -$12.1K |
|
|
HDSN
2627
Hudson Technologies
HDSN
$262M
| $62K | ﹤0.01% |
10,397
-1,702
| -14% | -$10.4K |
|
|
LLEX
2628
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
| $61K | ﹤0.01% |
12,097
-1,999
| -14% | -$9.65K |
|
|
EGLE
2629
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $59K | ﹤0.01% |
1,891
-311
| -14% | -$9.8K |
|
2630
Harmonic Inc
HLIT
$1.28B
| $57K | ﹤0.01% |
13,733
-5,322
| -28% | -$20K |
|
2631
Liquidity Services
LQDT
$1.23B
| $57K | ﹤0.01% |
+11,879
| New | +$64.7K |
|
2632
Kopin
KOPN
$693M
| $54K | ﹤0.01% |
17,444
+3,334
| +24% | +$11.5K |
|
|
WFT
2633
DELISTED
Weatherford International plc
WFT
| $54K | ﹤0.01% |
12,946
-2,747
| -18% | -$10.1K |
|
|
SRRA
2634
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $50K | ﹤0.01% |
333
-42
| -11% | -$4.04K |
|
2635
Enphase Energy
ENPH
$5.2B
| $47K | ﹤0.01% |
19,605
-3,350
| -15% | -$7.02K |
|
|
GNC
2636
DELISTED
GNC Holdings, Inc.
GNC
| $46K | ﹤0.01% |
+12,724
| New | +$80K |
|
|
CGNT
2637
DELISTED
Cogentix Medical, Inc.
CGNT
| $46K | ﹤0.01% |
14,560
-2,524
| -15% | -$7.27K |
|
|
CDMO
2638
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $42K | ﹤0.01% |
10,702
-1,336
| -11% | -$5.72K |
|
2639
Senseonics Holdings Inc
SENS
$272M
| $40K | ﹤0.01% |
760
-95
| -11% | -$5.28K |
|
|
DRRX
2640
DELISTED
DURECT Corp
DRRX
| $39K | ﹤0.01% |
4,315
-539
| -11% | -$6.41K |
|
|
ROX
2641
DELISTED
Castle Brands, Inc.
ROX
| $38K | ﹤0.01% |
31,448
-3,923
| -11% | -$4.87K |
|
|
PTN
2642
Palatin Technologies
PTN
$14.6M
| $37K | ﹤0.01% |
+34
| New | +$35.2K |
|
2643
Lee Enterprises
LEE
$175M
| $36K | ﹤0.01% |
1,521
-190
| -11% | -$4.45K |
|
2644
QuickLogic
QUIK
$238M
| $36K | ﹤0.01% |
1,464
-183
| -11% | -$4.12K |
|
|
NWY
2645
DELISTED
New York & Co Inc
NWY
| $36K | ﹤0.01% |
12,420
-1,551
| -11% | -$3.34K |
|
|
CASI
2646
DELISTED
CASI Pharmaceuticals
CASI
| $35K | ﹤0.01% |
1,088
-136
| -11% | -$3.69K |
|
2647
Galectin Therapeutics
GALT
$200M
| $35K | ﹤0.01% |
10,390
-1,298
| -11% | -$3.28K |
|
2648
Microvision
MVIS
$89.9M
| $35K | ﹤0.01% |
1,458
-180
| -11% | -$5.2K |
|
|
ZN
2649
DELISTED
Zion Oil & Gas, Inc.
ZN
| $35K | ﹤0.01% |
16,362
-2,043
| -11% | -$4.99K |
|
2650
Destination XL Group
DXLG
$30.4M
| $34K | ﹤0.01% |
15,530
-1,939
| -11% | -$3.94K |
|
Similar funds
TRSOTSOK
AIM
CII
AAMU
NMIFOAC
WANY
ACA
Guggenheim Capital's Q4 2017 Portfolio in Review
As of Q4 2017, Guggenheim Capital held 2,945 positions worth $42.2B, down 0.85% from $42.6B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.
Guggenheim Capital withdrew a net $2.32B in Q4 2017, closing 236 positions and reducing 1,320 holdings. Its most notable exit was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF, an estimated $84.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Guggenheim Capital opened a new position in iShares China Large-Cap ETF worth $18M.
- Guggenheim Capital's largest Q4 2017 buy was iShares China Large-Cap ETF: 389,755 shares worth $18M.
- Guggenheim Capital added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2017, an estimated $859M increase.
- Guggenheim Capital's biggest Q4 2017 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $106M.
- Guggenheim Capital fully exited CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF in Q4 2017, selling an estimated $84.5M.
- Guggenheim Capital's ten largest holdings make up 7.6% of its $42.2B portfolio in Q4 2017.
- Guggenheim Capital opened 147 new positions and closed 236 in Q4 2017.
- Guggenheim Capital's portfolio value fell 0.85% quarter-over-quarter to $42.2B.
Based on Guggenheim Capital's 13F filing for Q4 2017, filed 14 Feb 2018.